Finished
Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy
NCT05551364 · MarsiBionics · Updated 27 Sept 2024
- What is being tested
- ATLAS 2030 exoskeleton
- For
- Cerebral Palsy
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 3 years to 14 years. About 30 people. The full rules are on the registry page.
- Where
- Spain (6 sites)
- When
- Starts or started 5 Sept 2022, ends 30 Aug 2023. Registered 22 Sept 2022.
- Results
- None posted yet.
In the researchers' words
The main objective of this study is to assess the usability and efficacy of receiving therapy with the peaditric exoskeleton ATLAS 2030in children with gait impairment due to a cerebral palsy condition. It will be valued the impact of rehabilitation with the exoskeleton at the physical level on parameters such as joint range, spasticity, as well as the impact in quality of life. It is also assessed the impact at the level of functionality of the participants, through the administration of different functional assessment scales.
Sites
- Colegio de Educación Especial San Martín de Porres (ATADES)Zaragoza, Aragon, Spain
- ATENPACEMadrid, Spain
- Centre for Automation and Robotics, Marsi CareMadrid, Spain
- Fundación BobathMadrid, Spain
- Hospital Universitario Miguel ServetZaragoza, Spain
- Universidad de ZaragozaZaragoza, Spain